packageRivastigmine

rivastigmine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rivastigmine is an anticholinesterase medicine used to treat dementia, including Alzheimer's disease and Parkinson's disease dementia. It is approved and widely used, with several products authorised in the European Union for these conditions.

Summary written by glm-5.3-flash from Wikidata Q411887 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rivastigmine
ATC codes:N06DA03
DrugBank:DB00989
PubChem CID:77991
ChEBI:8874
Wikidata:Q411887
formula:C14H22N2O2
molar mass:250.342 g/mol (PubChem CID 77991)
logP:2.3 (Drugs.Common 25.09, not verified)

Metabolites

ZNS114666NAP22690ZNS 114-666 (NAP 226-90)molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
ZNS114666NAP22690metabolite: ZNS 114-666 (NAP 226-90)